HOME › DRUGS › TELAVANCIN
ACTIVE SUBSTANCE / INN

TELAVANCIN

Brand name(s): VIBATIV, Vibativ
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
WITHDRAWN
NDA022407
Pneumonia, Bacterial;Cross Infection
ACTIVE SUBSTANCE
Telavancin
REGULATORS
FDA · EMA
SPONSORS / MAH
THERAVANCE INC, Theravance Biopharma Ireland Umited, Astellas Pharma Europe B. V.
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VIBATIVNDA022407THERAVANCE INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VibativTheravance Biopharma Ireland UmitedWithdrawn02/09/2011Pneumonia, Bacterial;Cross Infection
VibativAstellas Pharma Europe B. V.Application withdrawnSkin Diseases, Infectious;Staphylococcal Infections;Soft Tissue Infections

FULL INTELLIGENCE ON TELAVANCIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →